Evaluating the effects of light and magnetic therapy in patients on mechanical ventilation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the effectiveness of photobiomodulation therapy combined with static magnetic field (PBMT-sMF) in adult patients requiring mechanical ventilation. It will compare the outcomes of patients receiving active PBMT-sMF alongside standard care to those receiving a placebo treatment. The primary objectives include determining if PBMT-sMF can reduce the length of ICU stay and increase diaphragm thickness in these patients. The study will be conducted as a multi-center, randomized, triple-blinded, placebo-controlled trial involving 112 participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Legally authorized representative signed informed consent;
* Male or female aged 21 years or older;
* On mechanical ventilation through orotracheal intubation for no more than 72 hours prior to study enrollment or pending mechanical ventilation through orotracheal intubation;
* Predicted to remain on mechanical ventilation for at least 48 hours (≥48 hours) from the time of study enrollment

Exclusion Criteria:

* Mechanical ventilation initiated longer than 72 hours prior to anticipated enrollment;
* Body Mass Index (BMI) \> 40 kg/m²;
* Fever of 100.4°C or higher;
* Situated in the prone position for 24 hours or longer during mechanical ventilation;
* Prognosis of mortality within 72 hours, per the patient's physician;
* Hypersensitivity to light;
* Use of non-invasive ventilation, Continuous Positive Airway Pressure (CPAP) and/or Bilevel Positive Airway Pressure (BiPAP) device for ≥ 50% of the time over the preceding 6 months;
* Tracheostomy;
* Any one or more of the following present on both sides of the neck (bilaterally) at the intended treatment site(s): internal jugular (IJ) venous cannulation; incisions, significant bruising; burn(s); notable skin irritation/rash, or other skin condition that may place the subject at risk from harm from the device treatment;
* Fracture, external or internal hemorrhage, or at risk of hemorrhage following acute trauma or fracture, or known or potential acute occult bleeding (e.g., gastric ulcer, intestine) in the intended treatment areas;
* Metallic device implants or body penetrating metallic devices in the upper body/neck area whose location may interfere with the study device treatment administration. E.g., extracorporeal membrane oxygenation (ECMO) cannula;
* Non-removable electrical/electronic device in the upper body/neck area that may interfere with the study device treatment administration, e.g., -implanted pacemaker or cardiac defibrillator;
* Cardiogenic or septic shock with ongoing severe hemodynamic instability (according to the American College of Chest Physicians definition (that cannot be stabilized within the 48 hours enrollment period);
* Conditions that may limit ultrasonographic assessment of diaphragmatic thickness, e.g., occluding chest drain, pleural effusion, pulmonary consolidation of the lower lobe(s);
* Current cancer of any type;
* Pregnancy;
* Any comorbidity, co-existing condition or illness, or other factor that in the opinion of the study investigator may render the subject unsuitable for participation in the study;
* Admission to the ICU within the last 12 months due to respiratory distress/failure;
* Two or more admissions to the ICU within the prior 12 months for any reason;
* Current participation in another clinical study.

Where it's running

• Santa Casa de Misericórdia de Porto Alegre
  Porto Alegre, Rio Grande do Sul, Brazil Recruiting

Study contacts

• Principal investigator: Ernesto Leal Junior, PhD — University of Nove de Julho
• Study coordinator: Ernesto Leal Junior, PhD
• Email: ernesto.leal.junior@gmail.com
• Phone: +551133859134

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HFNC During Bronchoscopy for Respiratory Failure

  This study tests whether using high-flow nasal oxygen during fiber-optic bronchoscopy is safe and helpful for patients with respiratory failure.

  Recruiting Mansoura University · Al Mansurah, Dakahlia Governorate · NCT07880964

• Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study

  This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.

  Recruiting at 13 sites Istituto Giannina Gaslini · Bologna and 12 other locations · NCT07879989

• Epidural spinal cord stimulation to help breathing after cervical spinal cord injury

  This trial tests whether adding epidural spinal cord stimulation to standard care can improve breathing in adults with cervical spinal cord injury and respiratory failure.

  Recruiting at 2 sites Zhongda Hospital · Nanjing, Jiangsu and 1 other locations · NCT07722130

• Brain blood flow and brain regulation in critically ill kids

  This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.

  Recruiting University of Wisconsin, Madison · Madison, Wisconsin · NCT07613918

• Ciprofol versus propofol for sedating adult ICU patients on noninvasive respiratory support

  See if ciprofol works better than propofol for sedating adults in the ICU who are receiving noninvasive ventilation, high-flow nasal cannula, or oxygen therapy.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07536750

• Using EEG to monitor sleep quality in ICU patients with respiratory failure

  We will test whether continuous EEG monitoring can better track sleep quality than nurse observations in conscious adults hospitalized in the ICU for acute respiratory failure.

  Recruiting University Hospital, Rouen · Rouen · NCT07522450

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.